TLIS News and Press, Talis Biomedical Corporation From 02/28/22

SAN FRANCISCO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to submit your losses now .   A securities class action has been filed concerning defendants’ representations during Ta...

San Francisco, California--(Newsfile Corp. - February 24, 2022) - Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to submit your losses now . A securities class action has been filed concerning defendants' representations during Talis' Feb. ...

Investor Notice: March 8th Deadline for Investors who Lost over $100,000 in Talis Biomedical Corporation shares announced by Shareholders Foundation PR Newswire SAN DIEGO , Feb. 22, 2022 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a deadline ...

TLIS Reminder: Kessler Topaz Meltzer & Check, LLP - March 8, 2022 Lead Plaintiff Deadline Reminder for Talis Biomedical Corporation Investors TLIS Reminder: Kessler Topaz Meltzer & Check, LLP - March 8, 2022 Lead Plaintiff Deadline Reminder for Talis Biomedical Corporati...

SAN FRANCISCO, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to submit your losses now .   A securities class action has been filed concerning defendants’ representations during Ta...

MENLO PARK, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced that Rob Ke...

MENLO PARK, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care (the “Company”...

Image source: The Motley Fool. Talis Biomedical Corporation (NASDAQ: TLIS) Q3 2021 Earnings Call Nov 15, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Talis Biomedical Corporation (TLIS) Q3 2021 Earnings Call Tran...

Talis Biomedical Corporation (TLIS) Q3 2021 Earnings Conference Call Nov 15, 2021 04:30 PM ET Company Participants Emily Faucette - Senior Vice President-Corporate Communications and Investor Relations Kim Popovits - Interim Chief Executive Officer Rob Kelly - Chief Commercial Officer Doug Li...

Talis Biomedical Corporation (NASDAQ:TLIS) posted better-than-expected revenue for Q3 2021 and announced its latest leadership change with the earnings release. The company has appointed Brian Blaser to President, Chief Executive Officer, and Director, replacing the interim CEO Kim Popov...